Stay updated on Pembrolizumab-Chemo, Olaparib Maint in EOC Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab-Chemo, Olaparib Maint in EOC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab-Chemo, Olaparib Maint in EOC Clinical Trial page

  1. Check
    2 days ago
    No Change Detected
  2. Check
    9 days ago
    Change Detected
    Summary
    The study page adds new sections for How to Read a Study Record, Common Questions, and How to Join a Study, and updates the Intervention/Treatment labeling; the Revision line updates from v3.5.5 to v3.6.0.
    Difference
    0.1%
    Check dated 2026-06-13T17:39:17.000Z thumbnail image
  3. Check
    16 days ago
    Change Detected
    Summary
    The page's revision label changed from v3.5.4 to v3.5.5, indicating a minor version update to the document.
    Difference
    0.0%
    Check dated 2026-06-06T14:41:48.000Z thumbnail image
  4. Check
    24 days ago
    Change Detected
    Summary
    Added Kharkiv Oblast and Kharkiv, Ukraine (61024) to the locations. Removed Kharkivs’ka Oblast’ and the corresponding Ukrainian entry.
    Difference
    0.0%
    Check dated 2026-05-30T12:21:31.000Z thumbnail image
  5. Check
    38 days ago
    Change Detected
    Summary
    The page now displays a new revision tag: v3.5.4, replacing the previous v3.5.3. This indicates an update to the site’s build or content framework rather than any change to the study details.
    Difference
    0.0%
    Check dated 2026-05-15T23:51:43.000Z thumbnail image
  6. Check
    45 days ago
    Change Detected
    Summary
    The study record now shows a completed status with updated timestamps marking the end of the trial's lifecycle; the former recruiting indicator and associated dates were removed to reflect that recruitment is finished and results may be posted.
    Difference
    0.1%
    Check dated 2026-05-08T23:12:03.000Z thumbnail image
  7. Check
    52 days ago
    Change Detected
    Summary
    Taoyuan District, Taiwan, 333 was replaced with Taoyuan, Taiwan, 333 in the locations list, updating the Taiwan study site address to reflect the correct city designation. This refines the site data to help participants identify and navigate to the correct study location.
    Difference
    0.0%
    Check dated 2026-05-01T20:18:58.000Z thumbnail image

Stay in the know with updates to Pembrolizumab-Chemo, Olaparib Maint in EOC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab-Chemo, Olaparib Maint in EOC Clinical Trial page.